Soerdjbalie-Maikoe, Vidija <br/><br/>
Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Jul 2004 
 - 958-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1619-7070 
<br/><br/><label>Standard No.: </label>10.1007/s00259-004-1479-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Bone Neoplasms--blood<br/>Cervical Vertebrae--diagnostic imaging<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Incidence<br/>Lumbar Vertebrae--diagnostic imaging<br/>Male<br/>Netherlands--epidemiology<br/>Prognosis<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Radionuclide Imaging<br/>Risk Assessment--methods<br/>Risk Factors<br/>Spinal Cord Compression--blood<br/>Thoracic Vertebrae--diagnostic imaging